MENU
KYTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Kyverna Therapeutics (KYTX) Ownership - Who owns Kyverna Therapeutics?
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
5980 Horton Street
Phone
+1 510 925-2492
Employees
96
Web
https://www.kyvernatx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
143.92M
P/E Ratio
N/A
Total Cash
242.65M
Projected Growth
N/A
Total Debt
6.94M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
5.61
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
KYTX
Capitalization
144M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
243M
Total Cash/Share
5.61
Total Debt
6.94M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
224M
P/B Ratio
0.64
Cash Flow
N/A
Earnings
-3.24
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
7.44
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-143.14M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-44.70
Shares Held By Institutions
53.9M
Shares Outstanding - Current
43.2M
Total Liabilities
36.6M
Total Volume MTD
N/A
Value
-1
Gain YTD
-10.963
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. KYTX showed earnings on March 27, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
5980 Horton Street
Phone
+1 510 925-2492
Employees
96
Web
https://www.kyvernatx.com